ObsEva Revenue and Competitors
Estimated Revenue & Valuation
- ObsEva's estimated annual revenue is currently $25M per year.
- ObsEva's estimated revenue per employee is $1,136,364
- ObsEva's current valuation is $147.4M. (January 2022)
Employee Data
- ObsEva has 22 Employees.
- ObsEva grew their employee count by -57% last year.
ObsEva Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is ObsEva?
Innovating Women's Reproductive Health and Pregnancy Therapeutics ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on treating endometriosis, uterine fibroids, preterm labor and improving ART outcomes. ObsEva is listed on The NASDAQ Global Select Market and is trading under the ticker symbol "OBSV". For more information, please visit www.ObsEva.com.
keywords:N/A
N/A
Total Funding
22
Number of Employees
$25M
Revenue (est)
-57%
Employee Growth %
$147.4M
Valuation
N/A
Accelerator
ObsEva News
HC Wainwright decreased their target price on ObsEva from $15.00 to $11.00 and set a buy rating for the company in a research report on Monday...
ObsEva is a biopharmaceutical company developing and commercializing novel therapies to improve women's reproductive health and pregnancy.
Obseva SA has a Long-Term Technical rank of 34. This means that trading over the last 200 trading days has placed the company in the lower half...
Other Companies in Plan-Les-Ouates
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.6M | 26 | 37% | N/A |
#2 | $6.5M | 26 | -26% | N/A |
#3 | $3.9M | 34 | 31% | N/A |
#4 | $5.4M | 35 | 3% | N/A |
#5 | $5.3M | 46 | -10% | N/A |